Jefferies London: Protagonist Therapeutics CEO Dinesh Patel responds to takeout speculation and discusses the company's programs and culture of partnering
Nov 18, 2025
10:06
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
He covers the company's oral IL-23 (partnered with JNJ), rusfertide (partnered with Takeda), and a new early stage obesity program.